Head-To-Head Survey: Orthofix Medical (OFIX) and The Competition

Orthofix Medical (NASDAQ:OFIX) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Orthofix Medical to related companies based on the strength of its analyst recommendations, profitability, valuation, risk, institutional ownership, earnings and dividends.

Analyst Ratings

This is a summary of current ratings and recommmendations for Orthofix Medical and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1	1	3	0	2.40
Orthofix Medical Competitors	4295	10588	18373	832	2.46

Orthofix Medical currently has a consensus price target of $14.75, indicating a potential upside of 106.01%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.96%. Given Orthofix Medical’s higher possible upside, research analysts plainly believe Orthofix Medical is more favorable than its competitors.

Insider and Institutional Ownership

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Orthofix Medical has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Orthofix Medical’s competitors have a beta of 2.57, suggesting that their average stock price is 157% more volatile than the S&P 500.

Profitability

This table compares Orthofix Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-5.39%	-10.32%	-5.19%
Orthofix Medical Competitors	-303.57%	-175.14%	-22.20%

Earnings and Valuation

This table compares Orthofix Medical and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Orthofix Medical	$822.31 million	-$92.19 million	-6.39
Orthofix Medical Competitors	$1.87 billion	$137.20 million	5.90

Orthofix Medical’s competitors have higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Orthofix Medical competitors beat Orthofix Medical on 7 of the 13 factors compared.

Orthofix Medical Company Profile

Orthofix Medical Inc. develops and markets medical technologies for spine and orthopedic care. Its products include spinal implants and biologics, bone growth stimulation systems, and solutions used in fracture treatment and limb reconstruction. The company serves hospitals, surgeons, and other health care providers through its Orthofix and SeaSpine businesses. Its offerings span surgical products as well as noninvasive and specialized orthopedic treatments. Orthofix and SeaSpine completed a merger in 2023, combining their spine and orthopedic product portfolios.